Pamiparib in combination with tislelizumab in patients with advanced solid tumours: results from the dose-escalation stage of a multicentre, open-label, phase 1a/b trial
Friedlander, Michael, Meniawy, Tarek, Markman, Ben, Mileshkin, Linda, Harnett, Paul, Millward, Michael, Lundy, Joanne, Freimund, Alison, Norris, Christie, Mu, Song, Wu, John, Paton, Virginia, Gao, BoLanguage:
english
Journal:
The Lancet Oncology
DOI:
10.1016/S1470-2045(19)30396-1
Date:
August, 2019
File:
PDF, 271 KB
english, 2019